| Announce Date | 12/12/2025 |
| EPS Normalized Actual | $2.17 (Beat by $0.06) |
| EPS GAAP Actual | $2.17 (Beat by $0.06) |
| Revenue Actual | $6.8B |
| Revenue Surprise | Beat by $6800M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2029 | 12.70141 | 25.39 | 12.09718 | 13.46517 | 2 |
| Oct 2028 | 10.73665 | 30.04 | 10.3158 | 11.37557 | 7 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.39 | 2.39 | 6.8B | -3.6% | 6800M |
| FQ3 2025 (Jul 2025) | 2.22 | 2.22 | 7.302B | 7.18% | 7302M |
| FQ2 2025 (Apr 2025) | 2.64 | 2.64 | 7.1B | 6.39% | 7100M |
| FQ1 2025 (Jan 2025) | 1.46 | 1.46 | 7.166B | 6.41% | 7166M |
| FQ4 2024 (Oct 2024) | 2.11 | 2.11 | 7.045B | 4.57% | 7045M |
| FQ3 2024 (Jul 2024) | 2.06 | 2.06 | 6.778B | 5.21% | 6778M |
| FQ2 2024 (Apr 2024) | 2.07 | 2.07 | 6.646B | 100% | 6646M |
| FQ1 2024 (Jan 2024) | 2.43 | 2.43 | 6.707B | -0.48% | 6707M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 3.04207 | -- | 2.99766 | 3.13042 | 7 |
| FQ3 2028 (Jul 2028) | 3.01036 | -- | 2.96641 | 3.09779 | 7 |
| FQ2 2028 (Apr 2028) | 2.98535 | -- | 2.94177 | 3.07206 | 7 |
| FQ1 2028 (Jan 2028) | 2.98142 | -- | 2.9379 | 3.06801 | 7 |
| FQ4 2027 (Oct 2027) | 2.86305 | -- | 2.83301 | 2.95311 | 18 |
| FQ3 2027 (Jul 2027) | 2.82434 | -- | 2.7947 | 2.91318 | 15 |
| FQ2 2027 (Apr 2027) | 2.76375 | -- | 2.73475 | 2.85069 | 12 |
| FQ1 2027 (Jan 2027) | 2.76 | -- | 2.6752 | 2.88198 | 7 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 8.48B | -- | 8.38B | 8.66B | 6 |
| FQ3 2028 (Jul 2028) | 8.47B | -- | 8.38B | 8.66B | 6 |
| FQ2 2028 (Apr 2028) | 8.42B | -- | 8.33B | 8.61B | 6 |
| FQ1 2028 (Jan 2028) | 8.36B | -- | 8.26B | 8.54B | 6 |
| FQ4 2027 (Oct 2027) | 8.47B | -- | 8.4B | 8.68B | 12 |
| FQ3 2027 (Jul 2027) | 8.41B | -- | 8.34B | 8.61B | 13 |
| FQ2 2027 (Apr 2027) | 8.26B | -- | 8.19B | 8.46B | 12 |
| FQ1 2027 (Jan 2027) | 8.12B | -- | 7.93B | 8.4B | 15 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.39 | 2.39 | 100% | |
| FQ3 2025 (Jul 2025) | 2.22 | 2.22 | 100% | |
| FQ2 2025 (Apr 2025) | 2.64 | 2.64 | 100% | |
| FQ1 2025 (Jan 2025) | 1.46 | 1.46 | 100% | |
| FQ4 2024 (Oct 2024) | 2.11 | 2.11 | 100% | |
| FQ3 2024 (Jul 2024) | 2.06 | 2.06 | 100% | |
| FQ2 2024 (Apr 2024) | 2.07 | 2.07 | 100% | |
| FQ1 2024 (Jan 2024) | 2.43 | 2.43 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $6.8B | $6800M | 100% |
| FQ3 2025 (Jul 2025) | $0B | $7.3B | $7302M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $7.1B | $7100M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $7.17B | $7166M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $7.05B | $7045M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $6.78B | $6778M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $6.65B | $6646M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $6.71B | $6707M | 100% |